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SUMMARY
There is a quest for the development of a new generation of vaccines consisting of well-defined 
subunit antigens. For a number of practical reasons it is attractive to develop vaccines on the basis 
of synthetic peptides. However, their efficacy may be limited by genetic restrictions imposed on 
T-cell recognition via major histocompatibility complex (MHC) polymorphism, as shown by many 
studies using inbred animal species. To study the effect of MHC polymorphism in an outbred 
species, we selected four cattle homozygous for different A-DR-DQ haplotypes, and another four 
cattle which shared one haplotype in combination with a haplotype of one of the MHC 
homozygous animals. We analysed responses to synthetic peptides comprising defined T-cell 
epitopes of foot-and-mouth disease virus (FMDY) in this selected group of FMDV-vaccinated 
cattle. This analysis shows that even in outbred animals, MHC polymorphism influences the 
responses to synthetic peptides. Interestingly, one of the peptides, VP4[20-34], was recognized in 
association with at least four different MHC haplotypes. Fine specificity analysis of this peptide 
revealed subtle shifts in the core epitope recognized. All peptides that induced lymphocyte 
proliferation in vitro were found to induce a T-helper type-1 (Thl) type of response, irrespective of 
the MHC haplotype involved. Together, these data support the notion that individuals carrying 
distinct MHC types can be vaccinated successfully by vaccines that include only a limited number 
of peptides. In the design of a peptide vaccine against FMDV we suggest inclusion of the highly 
conserved VP4 sequence 20-34.
INTRODUCTION
One of the novel approaches in vaccine research is the 
development of vaccines consisting of well-defined subunits of 
pathogen-derived antigens. Most attractive is the development 
of vaccines based on synthetic peptides comprising one or more 
B-cell epitopes and one or more T-cell epitopes of the pathogen. 
The advantages of such peptide vaccines include reduced costs 
and improved safety and quality in comparison to vaccines 
comprising the whole pathogen. They also comply with the 
growing requirement for marker vaccines that can discriminate 
between vaccinated and infected individuals. Moreover, by 
peptide vaccination it is possible to manipulate the immune 
system in such a manner that the production of protective 
neutralizing antibodies is induced,1 or that a non-responder to 
native antigen is converted into a responder.2
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However, especially in the development of such peptide 
vaccines, three aspects need special attention. First of all, 
polymorphism in pathogen-derived proteins often occurs 
in those parts of the proteins which are involved in 
immune recognition. In particular, RNA viruses, including 
foot-and-mouth disease virus (FMDV), contain regions 
with extremely high sequence variability.3 Consequently, 
T cells primed and antibodies elicited by a vaccine composed 
of sequences selected from such highly variable regions of 
the virus might not cross-react with virus occurring in the 
field.
A second major aspect to consider is the variability of the 
host immune response. A T-helper cell only recognizes an 
antigenic peptide in association with one of the major histo­
compatibility complex (MHC) class II products, expressed by 
antigen-presenting cells (APC).4 Each individual expresses its 
own set of MHC products coded by genes with a large allelic 
variation (i.e. MHC polymorphism). Hence, the MHC- 
restricted T-cell response frequently implies an individual- 
specific T-cell response towards peptides. This has been clearly 
demonstrated in many studies in which inbred mice strains were 
used.5,6
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Finally, the type of T-cell help induced by a peptide vaccine 
also has to be considered. Different cytokine profiles produced 
by T-helper cells lead to different effector functions. Again, 
studies in mice suggest that the type of effector function might 
also be controlled by MHC class II. In these studies a single 
peptide was able to elicit different types of T-cell help in 
different strains of mice.8
Here we studied the influence of MHC polymorphism on 
T-cell responses to peptides after vaccination with the whole 
pathogen in an outbred species, i.e. cattle. It has already been 
shown that T-cell responses are under control of MHC class II 
in cattle.9-12 Extensive studies on the MHC typing of cattle 
have revealed a high polymorphism comparable to that in 
humans.13 Upon detailed MHC typing of a large cattle herd, 
vaccinated with whole inactivated FMDV, we were able to 
select four animals homozygous for A-DR-DQ haplotypes and 
four related heterozygous animals. In this way proliferative and 
cytokine responses to three previously defined FMDV T-cell 
epitopes14 in association with six different MHC class II (DH) 
haplotypes could be examined.
MATERIALS AND METHODS
Virus
Viral antigen was prepared as described previously.14 Briefly, 
FMDV strain A10Holland was grown on a baby hamster 
kidney cell line (BHK21). Collected supernatant was treated 
with 0*04 m  binary ethyleneimine to inactivate the virus, and 
proteins were precipitated twice with 9% and 6% (w/v) 
polyethyleneglycol (6000 MW), respectively. Intact virus was 
purified on a CsCl2 equilibrium gradient. Purity was confirmed 
by SDS-urea-PAGE, as described by Meloen & Briaire.15 
The preparation was dialysed against phosphate buffer 
(pH 7-5), precipitated with 2 volumes of acetone at —20° and 
resuspended at a concentration of 1 mg/ml for in vitro 
restimulation of bovine peripheral blood mononuclear cells 
and proliferation assays.
Peptides
VP1 [35-53] (IMDRFVKINSLSPTHVIDL), VP2[74-88] 
(PFGHLTKLELPTDHH) and VP4[20-34] (SIINNYYMQ- 
QYQNSM) were synthesized by standard solid-phase Fmoc 
chemistry.16 These peptides were purified by reversed-phase 
high-performance liquid chromatography (HPLC) and the 
sequence was checked by amino acid composition analysis. Ten 
overlapping 15-mers, two 10-mers and one 7-mer covering the 
VP4 amino acid sequence 17-40 (indicated in Table 5) were 
prepared by automated simultaneous multiple peptide syn­
thesis, as described previously.14,17 All peptides were synthe­
sized with an amide group at the C-terminus.
Animals
Eight Holstein-Friesian cows were used. These animals were 
selected from the Wageningen Agricultural University (WAU) 
herd, the Netherlands. Selection was based on MHC type and 
family relationship. Four animals were homozygous for both 
MHC class I and class II, the other four animals were MHC 
heterozygous. This latter group included the four MHC class II 
haplotypes of the homozygous group, plus two additional ones. 
Three of the heterozygous animals had inherited the same 
paternal haplotypes as three animals of the homozygous group
Table 1. Interrelationship and MHC class II haplotypes of the selected
cattle
Animal no.*
Sire-code
fatherf
Sire-code 
via dami
Paternal
haplotype
Maternal
haplotype
A1983 026B 021A DH7A§ DH7A
A2399 060A 046A D H 8A D H 8A
A2346 060B 035B DH22B DH22B
A2390 051A 045A DH24A DH24A
A2396 060A 18*4 D H 8A DH18A
A2420 060B 0 11A DH22B DH7A
A2351 057B 159A DH22H DH18A
A2362 051A 159 A DH24A
\ j
DH J 8A
* Animals A1983, A2399, A2346 and A2390 were homozygous for 
MHC class I and MHC class II haplotypes. Animals A2396, A2420, 
A2351 and A2362 were heterozygous. Two extra DH haplotypes (22H 
and ISA) were included in this latter group.
f Code number of the fathers; note that three fathers of the homo­
zygous animals were shared by three animals from the heterozygous 
group.
$ Code number of the sire of which the haplotype was inherited via 
the mother.
§ Class II haplotype (DH), as shown in Table 2.
(Table 1). The age of the animals varied from 3 to 5 years. They 
all had been vaccinated at least once with the generally used 
trivalent FMDV vaccine, which is a mixture of strains 
A10Holland, O1BFSI86O and QDetmold, and were last 
revaccinated with monovalent vaccine type A, 6 months 
before the start of the experiments.
MHC typing
Class II polymorphism was established by serological, bio­
chemical and DNA typing techniques. Serological typing was 
performed by the two-colour fluorescence technique (TCT), as 
originally described by van Rood et ¿z/.,18 with minor 
modifications as described by Nilsson et al,19 Biochemical 
typing [immunoprécipitation and one-dimensional isoelectric 
focusing (1D-IEF)] was performed as described by Joosten 
et al.20 and Davies et al.21 The MHC class II antigens were 
precipitated with 3 /.¿I of the monoclonal antibody IL-A21 (a 
gift of Dr A. J. Teale, ILRAD, Nairobi, Kenya). Molecular 
typing was performed by two methods: detection of DRB3 
polymorphism by polymerase chain reaction-restriction frag­
ment length polymorphism (DRB3-PCR-RFLP) and detection 
of polymorphism of DQA and DQB by RFLP analysis. DRB3- 
PCR-RFLP typing was carried out essentially as described by 
van Eijk et a l22 DQ-RFLP was performed as described by 
Siguardardottir et al.23 For DQA-DQB typing, first and 
second domain (exon 2 and exon 3) DQA and DQB probes 
were used (clone DQA: W l, clone DQB: Yl). The sizes of 
the molecular weight fragments were adjusted on the basis of 
the BRL/Lifetechnologies (Baltimore, MD) lkb ladder. The 
nomenclature used for serotyping (Dw, De), 1D-IEF (DRBF) 
and DQA-DQB-RFLP was based on the nomenclature 
proposed at the Fifth International BoLA Workshop reported 
by Davies et a l24 The nomenclature used for DRB3-PCR- 
RFLP was based on the one proposed by van Eijk et al.22 Based 
on the combination of results of these four typing methods,
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Table 2. Defined MHC class II haplotypes (DH) Table 3. Cytokine primer sequences
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DH*
Ds
(serologyt)
DRBF
(IEFt)
DRB3
(PCR-RFLPf)
DQA
(RFLPf)
DQB
(RFLPf)
7A Dw2 02 7 2 2
8A Dwl; Dcl2 06 8 12 12
18A Dwl,4; Dc7 04 18 5 5
22B Dwl; Dc9 07 22 9B 9B
22HÎ Dw l, Dc9 07 22 9B 9A
24A Dw3 03 24 1A 1
* Class II haplotype (DH) reference numbers, according to the Fifth 
International Bovine Lymphocyte Antigen (BoLA) workshop.24 
t The method of typing is shown between parentheses.
X This haplotype was not officially defined during the Fifth Inter­
national BoLA workshop. The nomenclature used is as suggested by 
this workshop.24
class II haplotypes were defined. For each class II haplotype a 
D-haplotype (DH) code comparable to the one introduced in 
the class II report of the Fifth International BoLA Workshop24 
was used (Table 2). As MHC class I and class II are strongly 
linked, additional class I typing of the eight animals used in the 
study and class I and class II typing of related animals further 
confirmed the defined MHC class II haplotypes.
Proliferation assay
Proliferation assays were performed as described previously.14 
Briefly, peripheral blood mononuclear cells (PBMC) from the 
eight FMDV-vaccinated cattle were re stimulated by in ntro 
incubation with 0*25 ¿¿g/ml viral antigen for 7 days. After an 
expansion period of another 7 days in medium containing 
10IU/ml recombinant human interleukin-2 (IL-2) (Sanofit, 
Toulouse, France), cells were tested in a proliferation assay: 
cells were incubated for 5 days in 96-well flat-bottomed tissue 
culture plates (Costar, Cambridge, MA) at a concentration of 
2*5 x 105 cells/ml in the presence of freshly isolated irradiated 
autologous PBMC (1:1) and different concentrations of viral 
antigen or peptides. All cultures were performed in triplicate. 
During the last 18 hr of culture 0-4 ¿¿Ci [3H]thymidine (specific 
activity 1*0 Ci/mmol; Amersham International, Amersham, UK) 
was added to each well. Incorporation of label was assessed by 
liquid scintillation counting in a Betaplate-counter (Pharmacia, 
Uppsala, Sweden). Results were obtained as mean c.p.m.
i
Cytokine assays
For measurement of interferon-y (IFN-y), IL-2 mRNA and 
IL-4 mRNA, cells were pretreated as described above for the 
proliferation assay. Incubations with peptides were also 
’ performed in 96-well flat-bottomed plates (Costar) at an 
equal concentration. However, to minimize contamination of 
the RNA samples with RNA from APC, only adherent cells 
(from 105 irradiated PBMC/well) were used as APC. After 24, 
48 and 72 hr of incubation with peptides, non-adherent cells 
were harvested and washed with cold phosphate-buffered saline 
(PBS) for RNA isolation, and supematants were collected for 
determination of IFN-y. Different dilutions of the supernatants 
were assayed in duplicate for IFN-y using a commercial bovine 
IFN-y El A kit (Commonwealth Serum Laboratories, Parkville,
mRNA Strand Sequence
Actin + 5' CTGGCACGACACCTTCAACGAG 3'
— 5' AGCCAAGTCCAGACGCAGGATG 3'
IL-2 + 5' AAGTCATTGCTGCTGGATTTAC 3'
— 5' CCTGTAGTTCCAAAACGATTCTC 3'
IL-4 + 5' GCATTGTTAGCGTCTCCTGGTAAAC 3'
— 5' CTTCATAATCGTCTTTAGCCTTTCC 3'
+ reads 5'-3\ 
— reads 3'-5'.
Victoria, Australia) according to the manufacturer’s instruc­
tions. The use of this kit was described for the first time by 
Rothel et aL25
Total RNA was isolated from 107 cells by the use of 
RNAzol™ B (Campro Scientific, Veenendaal, the Nether­
lands) according to the manufacturer’s instructions- The 
amount of RNA was determined by OD26o and, if available,
10 fig of each sample was checked by electrophoresis in 
2% agarose/20% formaldehyde/20 mM 3-morpholino propane 
sulphonic acid (MOPS)/5mM sodium acetate/1 mM EDTA gel. 
Three samples of 5 /¿g RNA were used for reverse transcriptase- 
mediated synthesis of cDNA using the SuperScript™ pre­
amplification system (Gibco BRL, Paisley, UK) with oligo d(T) 
as a primer, according to the manufacturer’s instructions. From 
each reverse transcriptase reaction mixture (volume 20 fi\) 5-/il 
samples were subjected to PCR. Cytokine primers were 
designed from published cDNA sequences for bovine IL-226 
and IL-4,27 using PC/Gene release 6.7 software (IntelliGenetics 
Inc., Mountain View, CA), and were synthesized by OSWEL 
DNA services (University of Edinburgh, Edinburgh, UK). 
Sequences are shown in Table 3. Primers did not amplify 
products from genomic DNA. Actin primers were included as a 
control for quality of the cDNA product and PCR. PCR was 
performed at a final concentration of 10mM Tris-HCl pH 8*3, 
50 m M  KC1, 0*1 mg/ml gelatin, 8m M  MgCli, 0*2 m M  dNTP, 
0*5 /xm of the 5' and 3' primer, 2*5 U Thermus aquaticus DNA 
polymerase (Taq DNA polymerase) (Gibco BRL) in a total 
volume of 50 /¿l. The mixture was overlaid with paraffin oil 
(Sigma, St Louis, MO) and then amplified using a Techne 
PHC-3 thermal cycler. The amplification consisted of 30 cycles 
of the following profile: denaturation at 95° for 1 min, primer 
annealing at 55° for 1 min, and extension at 72° for 1 min. 
Twenty-five microlitres of each PCR reaction mixture was 
electrophoresed in 2% agarose gels in Tris borate/EDTA 
buffer. Gels were stained with ethidium bromide and photo­
graphed. Samples were indicated positive for the relevant 
product when bands of the expected size were visible.
RESULTS
In this study the influence of six bovine MHC class II 
haplotypes on the proliferation and cytokine production of T 
cells in response to three T-cell sites of FMDV (VP 1 [35-53], 
VP2[74-88] and VP4[20-34]), was examined. The six MHC 
class II haplotypes were present in eight cattle (Tables 1 and 2). 
PBMC from these cattle were restimulated once in vitro with
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Table 4. Proliferation of PBMC from selected cattle to intact inactivated FMDV and to peptides, representing three T-cell sites of FMDV
Animal no. A1983 A2399 A2346 A2390 A2420 A2396 A2351 A2362
DH* 7A/7A 8A/8A 22B/22B 24A/24A 22B/7A 8A/18A 22H/18A 24A/18A
BGf 4547 660 1285 6438 355 8603 123 4890
FMDV-antigenJ
Cone.
2*5 ¿ig/ml 42 68 17 21 122 23 57 32
VPl[35-53]§ 10- 5 m 6-9 1-2 1*1 0*3 5*7 12 86 28
10~6 m 6’6 1*1 1-5 0-5 3-0 20 62 23
10- 7 m 3*6 1*6 0-8 0*4 1*0 20 48 18
VP2[74-88] 10~5m 1-8 2*0 15 0*5 303 1*3 204 2*4
1 0 ~ 6 m 1-5 2*3 8-3 0*7 282 1-0 198 1*81
i 1 0 - 7 m 1'3 1*8 4*7 0-9 75 1-8 m 1*7
VP4[20-34] 10~5m 31 66 7*1 0*4 114 8-7 151 26
10~6m 24 44 3-0 H 13 5-3 74 . 16
10~7m 17 11 2-7 1-0 4*2 34 27 4-3
♦Class II haplotypes of the animals as shown in Table 1 and Table 2.
f BG, background proliferation of PBMC presented as c.p.m. The value obtained is the mean of 12 cultures.
f Proliferation to purified FMDV strain AioHolland presented as stimulation index (SI - proliferation to antigen/background proliferation). 
§ Proliferation to three molar concentrations of the peptide indicated, also presented as SI.
Bold numbers indicate SI values of 3-0 or higher. The standard deviation of the mean was 20% or less.
purified FMDV. Thereafter, cells were incubated with each 
peptide, representing one of the three T-cell sites, during which 
both proliferation and cytokine production were measured. 
Proliferation assays were performed using cells that were 
cultured for 5 days in the presence of different concentrations of 
each peptide or intact inactivated FMDV. Results are shown in 
Table 4. All cattle responded very well to intact FMDV: in all 
cases the stimulation index was greater than 15. Seven out of 
the eight animals also responded to one or more of the peptides. 
Peptide VP1 [35-53] was recognized by PBMC from animals 
carrying the DH7A or DH18A haplotypes. VP2[74~88] was 
recognized by PBMC from animals carrying the DH22B or 
DH22H haplotypes. Notably* peptide VP4[20-34] was recog­
nized by PBMC from most animals, indicating a promiscuous 
recognition in association with haplotypes DH7A, DH8A, 
DH22B and DH18A. The animal homozygous for the DH24A 
haplotype did not recognize any of the peptides.
Apart from a clear selectivity in the responses to the 
peptides, a difference in the magnitude of the responses was also 
observed. Animals carrying the DH7A haplotype responded 
more strongly to the VP4 than to the VP1 peptide, whereas the 
opposite proved to be the case for two out of three animals 
carrying the DH18A haplotype. In animals carrying the 
DH22B or DH22H haplotypes, the response towards the VP2 
peptide was most dominant, exceeding the response to the VP4 
peptide. Similarly, the heterozygous animal A2420, typed as 
DH22B/DH7A, responded to the three peptides, VP2[74-88], 
VP4[20-34] and VPI[35-53], with decreasing magnitude. 
Heterozygous animal A2351, typed as DH22H/DH18A, 
responded strongest to VP2[74-88] due to the presence of the 
DH22H haplotype. The responses to the VP1 and VP4 peptides 
were more or less equally high, due to the presence of the 
haplotypes DH 18A and DH22H, respectively.
For refinement of the recognition of the VP4 T-cell site by 
the different animals, a panel of 10 overlapping peptides, each
15 amino acids long, covering residues 17-40 of VP4, were 
tested using PBMC from animals A 1983 (DH7A), A2399 
(DH8A) and A2362 (DH18A/DH24A). Unfortunately, we 
were not able to use PBMC from animal A2346, which 
excluded analysis in the context of DH22B. The results are 
presented in Table 5. PBMC from animal A 1983 responded to 
six of the peptides, covering amino acid sequence 17-36, 
Peptides covering amino acid sequence 20-39 elicited the 
strongest proliferation of PBMC from animal A2399, High 
responses to all peptides, with the exception of VP4[26-40], 
were found with PBMC from animal A2362. Since it was shown 
that none of these peptide-specific responses was likely to occur 
via the DH24A haplotype, DH18A must have been the 
haplotype responsible for this effect. Deduced from these 
results, three shorter peptides were synthesized and tested. As 
expected, VP4[22-31] was recognized in association with 
haplotypes DH7A and DH18A, and VP4[25-34] was recog­
nized in association with haplotypes DH 8A and DH18A. 
However» the 7-mer VP4[25-31] was not recognized.
Cytokine production by the PBMC following peptide- 
specific stimulation was measured after 24, 48 and 72 hr 
incubation with no peptide or one concentration of each 
peptide. The cytokine assays were performed using PBMC 
from the three homozygous cattle (A1983, A2399 and A2346), 
which proliferated to one or two of the three peptides (Table 4). 
Results of the IFN-y assay are shown in Table 6 . IFN-y was 
found in all supernatants. However, a significantly higher 
concentration of IFN-y was present in 24-, 48- and 72-hr 
supernatants of cells that specifically proliferated to peptide, as 
shown by enhanced [3H]thymidine incorporation after 5 days 
of incubation. The presence of transcripts for IL-2 and IL-4 was 
tested by PCR using specific primers. In all 24- and 72-hr 
samples, IL-2 mRNA could be detected easily (data not 
shown). IL-4 mRNA was not detected in any sample of cells 
specifically proliferating to peptide. IL-4 mRNA was only
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Table 5. Proliferation of PBMC to a panel of overlapping VP4 peptides
Animal no.
DH
BG*
A1983
7A/7A
565
A2399
8A/8A
588
A2362 
24 A/18 A 
589
FMDV-antigenf -J-1_ + + + + +
VP4 peptides
17-31J + + +§ — + + +
18-32 + H—f* — + + +
19-33 H—H + + + +
20-34 + + + + + + + +
21-35 H—h + + + + + + +
22-36 H—h _j_ _|_ _|_ + + +
23-37 - -j. ^ + + +
24-38 - lijn 1« + + +
25-39 - + + -f +
26-40 ------ + —
22-31 + + — + + +
25-34 ------ + + + +
25-31 —
Table 6 . Proliferation, IFN-y secretion and detection of IL-4 mRNA by 
or in PBMC incubated with no peptide or with each peptide, repre­
senting one of the three FMDV T-cell sites
* BG, background proliferation of PBMC presented as c.p.m. The 
value obtained is the mean of 12 cultures.
f Proliferation to 2-5/ig/ml purified FMDV strain Ai0Holland.
| Proliferation to 5 x 10~5m of the VP4 peptides. Peptide sequence 
is indicated by first and last amino acid of the VP4 amino acid sequence.
§ + + + =SI>100; + + = 10 < SI < 100; + =3*0 < SI <10;
SI < 3*0. (SI = stimulation index). The standard deviation of mean was 
20% or less.
clearly detectable in 48- and 72-hr samples derived from cells 
proliferating non-specifically (Table 6). The enhanced IFN-y 
secretion and no or decreased IL-4 transcription by cells 
specifically proliferating to the peptides indicated a shift 
towards a T-helper type-1 (Thl) type of response.
DISCUSSION
An attractive approach in vaccine development is the 
generation of vaccines based on synthetic peptides. However, 
since it is known that T cells recognize antigenic peptides only 
in association with products of the polymorphic MHC,4 such a 
peptide vaccine may be effective only in a selected group of 
individuals. Here we studied the effect of bovine MHC class II 
polymorphism on the proliferative and cytokine responses to 
three T-cell sites of FMDV.
To refer to the complete MHC class II haplotype, we used 
the D haplotype (DH), as defined by several typing techniques 
for both the DR and DQ regions ( = Ds type + DRB3 PCR- 
RFLP type + DRBF-type + DQA-RFLP type + DQB-RFLP 
type), A clear correlation between the MHC class II haplotype 
and the response to a particular peptide was found, which is 
summarized in Table 7. Although Holstein-Friesians were 
used throughout this study, D haplotypes 7A, 8A, 18A and 22B 
have also been found in other breeds of cattle.24 So the three 
peptides are likely to be effective in other breeds of cattle as 
well. It is not certain whether the recognition of VP4[20~34] is 
possible in the context of the DH22H haplotype. This 
haplotype was only present in a heterozygous animal (A2351) 
that also carried the DH18A haplotype, which itself is
Relative IL-4 
SI* IFN-y conc.j mRNA
Incubation time (hr) 114 24 48 72 48/72
A1983J No peptide 1-0 1-0 1*0 1*0 +
(DH7A/DH7A) ' VP1[35~53]§ 3-1 1*8 1*4 1-4 -
VP2[74-88] 1-0 1-0 1*0 1*0 +
VP4[20-34] 19'3 3*4 4*7 3*1 —
A2399 No peptide 1*0 1*0 1*0 1*0 +
(DH8A/DH8A) VP 1 [35-53] 1*0 1*0 0*9 1-0 +
VP2[74—88] 1-0 1*0 1*1 1*0 +
VP4[20-34] 7*8 2*4 3*9 3*5 —
A2346 No peptide 1*0 1*0 1*0 1*0 +
(DH22B/DH22B) VP 1 [35-53] 1*3 1*2 1*2 1*0 +
VP2[74-88] 22-2 2*7 3*5 3*1 -
VP4[20“34] 3*4 2*3 2*6 3*2 —
* Proliferation of cells was measured by a 5-day proliferation assay. 
SI (stimulation indices) are shown.
f Eight times diluted supernatants of cells were tested in an IFN-y 
ELISA kit. Relative IFN-y concentration was calculated as the ratio of 
the OD450 value obtained from the supernatant and the OD450 value 
obtained from the supernatant of the same cells incubated without peptide.
X Animal from which PBMC were tested with, between parentheses, 
the MHC class II haplotype (DH) as shown in Table 2.
§PBMC were incubated with 10"6m of the peptides indicated. 
Bold numbers indicate SI > 3*0, OD450 ratios > 1*3 and samples in 
which no IL-4 mRNA was detected.
responsible for a response towards this peptide. However, 
VP4[20~34] is recognized in association with the DH22B 
haplotype (animal A2346) which is, with respect to DR type, 
identical to the DH22H haplotype. Furthermore, the magni­
tude of the response to VP4[20~34] by PBMC from animal 
A2351 was clearly enhanced compared to the response to this 
peptide in the context of the DH18A haplotype only (as shown 
by animal A2362). Based on both observations, we suggest that 
VP4[20-34] might also be recognized in the context of the 
DH22H haplotype.
The recognition of this VP4 T-cell site in the context of the 
DH7A, DH8A and DH18A haplotypes was studied in more 
detail. A difference in the 4core' sequences was observed for
Table 7. Association between the T-cell sites recognized by PBMC from 
FMDV-vaccinated cattle and their MHC class II haplotype (DH) or
associated DRB3-PCR-RFLP type
DH
a
DRB3-PCR-RFLP VP1[35—53] VP2[74-88] VP4[20-34]
7A 7 + — * +
8A 8 — — +
18A 18 + — +
22B 22 + +
22H 22 — + + ?
24A 24
1
— —
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recognition in the context of these different haplotypes: amino 
acid 22 (to 31 or less) of VP4 was essential for recognition in the 
context of the DH7A haplotype: for the DH8A haplotype, 
amino acid 33 (from 26 or more) was required, although 
responses increased dramatically as soon as amino acid 34 was 
included; and finally, in the context of the DH18A haplotype, 
the critical sequence seemed to include amino acid 25 (to 31 or 
less). However, the 7-mer VP4[25-31] was not recognized in the 
context of the DH18A haplotype. Apparently this relatively 
short peptide is much less effective in MHC binding and/or 
T-cell activation, as has been found in many other studies on 
T-cell responses to truncated peptides.28’29 Another possibility 
is that in the context of the DH18A haplotype more than one 
‘core’ sequence within the VP4 sequence 17-39 is present, one 
within region 22-31 and the other within region 25-34, each 
binding to the same or to different MHC class II molecules (e.g. 
DR and DQ). These kinds of shifts in ‘core5 sequences within 
one promiscuous T-cell site of an antigen have been described 
before.30 Analysis of such a T-cell site indicated that the peptide 
assumed different conformations upon interaction with dif­
ferent MHC molecules.31
We did not observe a significant shift in cytokine profiles of
PBMC that were derived from animals carrying different MHC
class II haplotypes, but that proliferated to the same peptide.
Similarly, no differences in cytokine profiles of PBMC that
were derived from a single animal but that specifically
proliferated to different peptides could be found. PBMC that
specifically proliferated to peptide were all found to secrete
more IFN-y and less IL-4 than non-specifically proliferating
cells, indicating a shift towards T-helper cells of the Thl
f t
subtype upon pep tide-specific stimulation.
We do not know whether the responses to the FMDY 
peptides, reported here, are restricted via DR, DQ or maybe 
even other products expressed from the bovine MHC class II 
region,32’33 Evidence of DR and/or DQ restriction might be 
obtained by testing other MHC-typed cattle matched either for 
DR or DQ. However, selection of such animals will not be easy, 
since DQ and DR are in strong linkage disequilibrium.34,35 
Alternatively, the use of blocking DR- and DQ-specific 
monoclonal antibodies (mAb) or direct MHC-peptide bind­
ing assays could be informative in this matter. However, well- 
defined mAb are currently unavailable for these studies.
Knowledge of the precise restriction element is not 
necessarily essential for the prediction of the effectiveness of a 
peptide in a MHC-typed animal. Cross-overs between the 
different MHC class II loci appear to be limited, leading to a 
strong linkage between DR, DQ and probably also other
a  i  ^  f
products. ’ Thus, in general, typing for only one MHC class 
II product might be sufficient to predict the outcome of the 
response towards a peptide. Although about 600 animals of the 
WAU herd are typed for DRB3 by PCR-RFLP, only a few 
animals are typed for the complete MHC class II haplotype. If 
we consider our findings for this population of 600 animals, the 
following predictions can be made with regard to the successful 
implementation of peptide vaccines (for this purpose the 
DRB3-PCR-RFLP types, associated with the DH haplotypes 
studied so far, are included in Table 7). Complete non­
responsiveness to the three FMDV peptides was observed for 
the DH24A haplotype. Seventeen animals in the typed WAU 
herd were found to be homozygous for DRB3*24, a DRB3 type 
which is found to occur exclusively in the DH24A haplotype.
Thus, only 3% of non-responders from the total herd of 600 
animals would be expected, on the basis of the frequency of the 
DH24A haplotype. To date, 32 DRB3-PCR-RFLP types have 
been defined. So far, four of these have been shown to be 
associated with a response to VP4[20-34]. Yet, 60% of the 
WAU herd was positive for one or two of these four responder 
DRB3-PCR-RFLP types. If the distribution of class II 
haplotypes is representative for the Holstein-Friesian breed 
in general, VP4[20-34] would be a good candidate for inclusion 
in a peptide vaccine, especially since this site is derived from a 
highly conserved region of the virus as well. The amino acid 
sequence ofVP4[20-34] is 100% identical between serotypes A, 
O and C of FMDY. An effective synthetic vaccine might be 
generated for example by coupling the YP4 T-cell site in 
combination with one or more B-cell epitopes to the 
lipotripeptide (P3CSS), as studied by Wiesmuller et al.36 or by 
inclusion of the peptides into liposomes.37
In conclusion, these findings show for the first" time that a 
strong MHC-restricted selection of T-cell epitopes also occurs 
in an outbred population like cattle. This will have major 
implications for research on vaccine development, and for the 
design of synthetic vaccines in particular. The influence of 
MHC polymorphism may be less apparent in the response to 
complete viral proteins. Still, the effect of MHC polymorphism 
must not be under-estimated when testing new subunit vaccines 
in randomly chosen groups of animals. In order to establish the 
efficacy of the vaccine in different MHC backgrounds, the 
animals used should be typed in advance. Then groups of 
animals can be selected in which the most frequent MHC class
II types are represented and equally distributed. For the 
development of a peptide vaccine, MHC polymorphism will
*
surely have an influence, as we have shown here. In order to 
design a peptide vaccine which is effective in ail animals, the 
response to different T-cell epitopes should be tested for all 
possible MHC haplotypes. For this kind of study homozygous 
animals are indispensable. Finally, a combination of a limited 
number of peptides, covering a T-cell response in association 
with all haplotypes should be included in the vaccine, The 
present study shows that for this purpose conserved and 
promiscuous epitopes of a complex pathogen like FMDV can 
be found that largely circumvent the MHC-related restriction 
even in an outbred population.
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